News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
161 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44431)
2016 (38329)
2017 (37186)
2018 (39119)
2019 (51334)
2020 (57662)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37440)
2025 (33091)
2026 (29199)
Month
January (3217)
February (3391)
March (3462)
April (3660)
May (4506)
June (2887)
July (2191)
August (2499)
September (2720)
October (3233)
November (3383)
December (2291)
Day
1 (168)
2 (144)
3 (119)
4 (78)
7 (116)
8 (161)
9 (155)
10 (156)
11 (59)
14 (75)
15 (187)
16 (113)
17 (182)
18 (78)
20 (6)
21 (130)
22 (103)
23 (158)
24 (166)
25 (146)
28 (152)
29 (195)
30 (196)
31 (190)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
7
8
9
10
11
14
15
16
17
18
20
21
22
23
24
25
28
29
30
31
Press Releases
Soleno Therapeutics Announces Regulatory Update on DCCR (diazoxide choline) Extended-Release Tablets to Treat Prader-Willi Syndrome
October 8, 2024
·
4 min read
Press Releases
Cerevance Achieves Second Milestone in Research Collaboration with Merck
October 8, 2024
·
2 min read
Press Releases
CytoDyn Appoints Dr. Max Lataillade as Senior Vice President and Head of Clinical Development
October 8, 2024
·
3 min read
Press Releases
Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
October 8, 2024
·
3 min read
Press Releases
Jaguar Health Submits Abstract for First-of-Kind Study Evaluating the Impact of Diarrhea from Cancer Therapies in Breast Cancer Patients Who Received Placebo in its OnTarget Phase 3 Trial
October 8, 2024
·
4 min read
Press Releases
CENTENE CORPORATION TO HOST 2024 THIRD QUARTER FINANCIAL RESULTS EARNINGS CALL
October 8, 2024
·
1 min read
Press Releases
GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 Newborns
October 8, 2024
·
3 min read
Press Releases
Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings
October 8, 2024
·
6 min read
Press Releases
Clarity enters a Clinical Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
October 8, 2024
·
1 min read
Alzheimer’s disease
Sage Suffers Third Neuro Stumble in Six Months With Disappointing Mid-Stage Alzheimer’s Readout
Sage has decided to discontinue the development of dalzanemdor in Alzheimer’s disease. A study of the candidate in Huntington’s is ongoing, with early data expected later this year.
October 8, 2024
·
2 min read
·
Tristan Manalac
Previous
14 of 17
Next
